WH’s Top 5 Q3 Trades

WHITTIER TRUST CO recently filed its 13F report for the third quarter of 2022, which ended on 2022-09-30.

The 13F report details the stocks that were in a guru’s stock portfolio at the end of the quarter, although investors should note that these filings are limited in scope, containing only an overview of long stock positions. listed in the United States and American certificates of deposit at the end of the quarter. They are not required to include international holdings, short positions or other types of investments. Yet even this limited repository can provide valuable information.

Whittier Trust Co is an investment management firm based in South Pasadena, California. The company was established in 1935 and today offers a “breadth of financial services and expertise backed by an exceptional commitment to personalized service reflecting our family office roots”. Whittier Trust is an independent firm that is currently “the oldest and largest multi-family office headquartered on the West Coast”. Whittier Trust Co conducts research both internally and externally to create a “unique perspective that combines macroeconomic forecasts and individual company analysis” and focuses on the alternative investment market, in particular on real estate, private equities and oil and gas. The company invests the most in the financial sector, which alone accounts for more than a third of the firm’s total asset allocation, and also invests in the sectors of information technology, healthcare, consumer staples, consumer discretionary, industrials and energy, among other sectors. to a lesser extent, in descending order of allocation. Whittier Trust holds its allocations for 11.5 quarters on average and holds its top 10 allocations, which represent more than a fifth of its total asset allocations, for around the same amount at 11.7 quarters on average. During the last quarter, Whittier Trust experienced a turnover rate of approximately 14.9%. The company’s top holdings include SPDR S&P 500 ETF Index Certificates of Deposit, iShares Russell 2000 Index Fund, Apple Inc, Johnson & Johnson Co., JPMorgan Chase & Co., Exxon Mobil Corp., SPDR S&P MidCap 400 ETF Trust and 3M Company, in descending order of allocation. Whittier Trust has developed a Wealth Management Framework to “give a structure and methodology to help you analyze, assess and improve your overall wealth management picture”. The company is focused on growing and maintaining wealth by maximizing after-tax and risk-adjusted returns, with a focus on a long-term horizon.

According to the latest 13F report, the guru’s stock portfolio contained 1709 stocks valued at a total of $4.77 billion. The main holdings were
AAPL(5.03%),
MSFT(3.96%) and
TO SPY(3.74%).

According to data from GuruFocus, these were WHITTIER TRUST CO’s top five deals of the quarter.

Mexican Chipotle Grill Inc

During the quarter, WHITTIER TRUST CO purchased 11,773 shares of NYSE:CMG for a total holding of 12,096. The transaction had a 0.37% impact on the equity portfolio. During the quarter, the stock traded at an average price of $1,549.91.

On 10/21/2022, Chipotle Mexican Grill Inc traded at a price of $1526.2 per share and a market capitalization of $42.33 billion. The stock has returned -17.31% over the past year.

GuruFocus gives the company a financial strength rating 6 out of 10 and one profitability rating out of 9 out of 10.

In terms of valuation, Chipotle Mexican Grill Inc has a price/earnings ratio of 57.10, a price/book ratio of 19.69, a price/earnings/growth (PEG) ratio of 1.84, an EV/ Ebitda of 36.90. and a price-to-sales ratio of 5.30.

The GF price/value ratio is 0.84, which earns the stock a GF Value Ranking of 6.

iShares Core S&P 500 ETF

During the quarter, WHITTIER TRUST CO bought 37,989 shares of ARCA:IVV for a total stake of 415,254. The transaction had an impact of 0.29% on the equity portfolio. During the quarter, the stock traded at an average price of $397.41.

On 10/21/2022, the iShares Core S&P 500 ETF traded at a price of $373.1693 per share and a market capitalization of $280.67 billion. The stock has returned -16.86% over the past year.

The data is insufficient to calculate the financial strength and profitability of the title.

In terms of valuation, iShares Core S&P 500 ETF has a price-to-earnings ratio of 18.29 and a price-to-book ratio of 3.43.

Starbucks Corp.

WHITTIER TRUST CO reduced its investment in NAS:SBUX by 186,730 shares. The transaction had an impact of 0.29% on the equity portfolio. During the quarter, the stock traded at an average price of $84.95.

On 10/21/2022, Starbucks Corp traded at a price of $88.13 per share and a market capitalization of $101.15 billion. The stock has returned -21.25% over the past year.

GuruFocus gives the company a financial strength rating 4 out of 10 and one profitability rating out of 9 out of 10.

In terms of valuation, Starbucks Corp has a price/earnings ratio of 24.84, a price/earnings/growth (PEG) ratio of 5.07, an EV/EBITDA ratio of 16.47 and a price/sales ratio of 3. ,23.

The GF price/value ratio is 0.75, which earns the stock a GF Value Ranking of 9.

SPDR Biotech ETF

During the quarter, WHITTIER TRUST CO bought 158,110 shares of ARCA:XBI for a total stake of 264,625. The transaction had an impact of 0.26% on the equity portfolio. During the quarter, the stock traded at an average price of $84.31.

On 10/21/2022, the SPDR Biotech ETF traded at a price of $78.34 per share and a market capitalization of $6.77 billion. The stock has returned -36.66% over the past year.

The data is insufficient to calculate the financial strength and profitability of the title.

In terms of valuation, SPDR Biotech ETF has a price-to-book ratio of 3.42.

iShares Biotechnology ETF

WHITTIER TRUST CO reduced its investment in NAS:IBB by 99,645 shares. The transaction had an impact of 0.23% on the equity portfolio. During the quarter, the stock traded at an average price of $124.02.

On 10/21/2022, iShares Biotechnology ETF traded at a price of $120.39 per share and a market capitalization of $7.52 billion. The stock has returned -23.93% over the past year.

The data is insufficient to calculate the financial strength and profitability of the title.

In terms of valuation, iShares Biotechnology ETF has a price-to-earnings ratio of 13.23 and a price-to-book ratio of 4.25.

Please note that figures and facts quoted are at the time of writing this article and may not reflect the latest business data or company announcements.

You want to give your opinion on this article ? Do you have questions or concerns? Contact us hereor email us at [email protected]!

This article is general in nature and does not represent the views of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendation. It has been written without taking into account your personal situation or financial goals. Our goal is to bring you data-driven fundamental analysis. The information on this site is in no way guaranteed to be complete, accurate or in any other way.

Comments are closed.